Evidence map›Paper›PMID 36836078›Full record

ReviewJournal of clinical medicine2023

Multidisciplinary Guidelines for the Rational Use of Topical Non-Steroidal Anti-Inflammatory Drugs for Musculoskeletal Pain (2022).

Chen Shi, Zhaoming Ye, Zengwu Shao, Bifa Fan, Cibo Huang, Yuan Zhang, Xinying Kuang, Liyan Miao, Xin'an Wu, Rongsheng Zhao and 36 more

Open access · goldAbstract readReview
In one paragraph

Review in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

46 authors at 15 institutions in 3 countries.

Chen ShiDepartment of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (HUST), Wuhan 430022, China.
Zhaoming YeDepartment of Orthopedics, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China.
Zengwu ShaoDepartment of Orthopaedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (HUST), Wuhan 430022, China.
Bifa FanDepartment of Pain Management, China-Japan Friendship Hospital, Beijing 100029, China.
Cibo HuangDepartment of Rheumatology, South China Hospital, Health Science Center, Shenzhen University, Shenzhen 518116, China.
Yuan ZhangDepartment of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON L8S 4K1, Canada.
Xinying KuangGlobal Health Nursing, St. Luke's International University, Tokyo 104-0044, Japan.
Liyan MiaoDepartment of Pharmacy, The First Affiliated Hospital of Soochow University, Suzhou 215006, China.
Xin'an WuDepartment of Pharmacy, The First Hospital of Lanzhou University, Gansu 730000, China.
Rongsheng ZhaoDepartment of Pharmacy, Peking University Third Hospital, Beijing 100191, China.
Xiao ChenDepartment of Pharmacy, The First Affiliated Hospital of Sun Yet-sen University, Guangzhou 510080, China.
Bikui ZhangDepartment of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha 410011, China.
Rongsheng TongDepartment of Pharmacy, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, China.
Xin HuDepartment of Pharmacy, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing Key Laboratory of Drug Clinical Risk and Personalized Medication Evaluation, Beijing 100730, China.
Zhijian FuDepartment of Pain Management, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, China.
Jianhao LinArthritis Clinic and Research Center, Peking University Peoples Hospital, 11 Xizhimen South Street, Xicheng District, Beijing 100044, China.ORCID 0000-0003-1830-9244
Xiaomei LiDepartment of Rheumatology and Immunology, The First Affiliated Hospital of USTC, University of Science and Technology of China, Lujiang Str. 17, Hefei 230001, China.
Tiezheng SunArthritis Clinic and Research Center, Peking University Peoples Hospital, 11 Xizhimen South Street, Xicheng District, Beijing 100044, China.
Guoqiang LiuDepartment of Clinical Pharmacy, The Third Hospital of Hebei Medical University, Shijiazhuang 050051, China.ORCID 0000-0003-3838-716X
Haibin DaiDepartment of Pharmacy, Second Affiliated Hospital of Zhejiang University School of Medicine, Research Center for Clinical Pharmacy, Zhejiang University, Hangzhou 310009, China.ORCID 0000-0002-5768-2714
Cheng GuoDepartment of Pharmacy, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China.
Bo ZhangDepartment of Pharmacy, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Hospital, Beijing 100730, China.
Ting XuDepartment of Pharmacy, West China Hospital, Sichuan University, Chengdu 610041, China.
Aidong WenDepartment of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.
Xiaocong ZuoDepartment of Pharmacy, The Third Xiangya Hospital, Central South University, Changsha 410013, China.
Jinmei LiuDepartment of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (HUST), Wuhan 430022, China.
Xu ChenDepartment of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (HUST), Wuhan 430022, China.
Huibo LiDepartment of Pharmacy, Peking University Third Hospital, Beijing 100191, China.ORCID 0000-0001-6807-8099
Jing WangDepartment of Pharmacy, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China.
Min LuoDepartment of Pharmacy, West China Hospital, Sichuan University, Chengdu 610041, China.ORCID 0000-0001-9322-7279
Tingting FanDepartment of Pharmacy, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, China.
Yulan QianDepartment of Pharmacy, The First Affiliated Hospital of Soochow University, Suzhou 215006, China.
Xiu'mao LiDepartment of Orthopedics, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China.
Wenjie QiuDepartment of Rheumatology, South China Hospital, Health Science Center, Shenzhen University, Shenzhen 518116, China.
Xiaowen LinDepartment of Pain Management, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, China.
Yingchang PangArthritis Clinic and Research Center, Peking University Peoples Hospital, 11 Xizhimen South Street, Xicheng District, Beijing 100044, China.
Yunfei HouArthritis Clinic and Research Center, Peking University Peoples Hospital, 11 Xizhimen South Street, Xicheng District, Beijing 100044, China.
Difei YaoDepartment of Pharmacy, Second Affiliated Hospital of Zhejiang University School of Medicine, Research Center for Clinical Pharmacy, Zhejiang University, Hangzhou 310009, China.
Wen KouDepartment of Pharmacy, The First Hospital of Lanzhou University, Gansu 730000, China.
Bao SunDepartment of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha 410011, China.
Can HuDepartment of Pharmacy, The Third Xiangya Hospital, Central South University, Changsha 410013, China.
Yanzhe XiaDepartment of Pharmacy, The First Affiliated Hospital of Sun Yet-sen University, Guangzhou 510080, China.
Ming ZhaoDepartment of Pharmacy, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing Key Laboratory of Drug Clinical Risk and Personalized Medication Evaluation, Beijing 100730, China.
Changyu ZhuDepartment of Pharmacy, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, China.
Qian LiDepartment of Clinical Pharmacy, The Third Hospital of Hebei Medical University, Shijiazhuang 050051, China.
Yu ZhangDepartment of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology (HUST), Wuhan 430022, China.
Union Hospital · CNCentral South University · CNPeking University · CNHebei Medical University · CNShanghai Jiao Tong University · CNSoochow University · CNUniversity of Science and Technology of China · CNSecond Affiliated Hospital of Zhejiang University · CNSichuan University · CNSun Yat-sen University · CNUniversity of Electronic Science and Technology of China · CNChina-Japan Friendship Hospital · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNShandong Provincial Hospital · CNShenzhen University Health Science Center · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

(1) Background: Topical non-steroidal anti-inflammatory drugs (NSAIDs) are one of the primary drugs for treating musculoskeletal pain. However, there are currently no evidence-based recommendations about drug selection, drug administration, drug interactions, and use in special populations or other pharmacology-related content of such medications. To this end, the Chinese Pharmaceutical Association Hospital Pharmacy Professional Committee developed multidisciplinary guidelines on using topical NSAIDs to treat musculoskeletal pain. (2) Methods: The guidelines development process followed the World Health Organization guideline development handbook, the GRADE methodology, and the statement of Reporting Items for Practice Guidelines in Healthcare. The guideline panel used the Delphi method to identify six clinical questions to be addressed in the guidelines. An independent systematic review team conducted a systematic search and integration of evidence. (3) Results: Based on the balance between the benefits and harms of an intervention, the quality of the evidence, patient preferences and values, and resource utilization, the guideline panel developed 11 recommendations and nine expert consensuses on using topical NSAIDs to treat acute and chronic musculoskeletal pain. (4) Conclusions: Based on the effectiveness and overall safety of topical NSAIDs, we recommend patients with musculoskeletal pain use topical NSAIDs and suggest high-risk patients use topical NSAIDs, such as those with other diseases or receiving other concurrent treatments. The evidenced-based guidelines on topical NSAIDs for musculoskeletal pain incorporated a pharmacist perspective. The guidelines have the potential to facilitate the rational use of topical NSAIDs. The guideline panel will monitor the relevant evidence and update the recommendations accordingly.

Indexed as

guidelinesmusculoskeletal painpain managementtopical non-steroidal anti-inflammatory drugs

Identifiers

PMID36836078
PMCPMC9966446
OpenAlexW4321097005

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.